New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|8|1|12-37

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.8, Iss.1, 2008-01, pp. : 12-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pancreatic Neuroendocrine Tumors: Signal Pathways and Targeted Therapies

By  

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-01 ,pp. : 333-339

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Mediators of Vitamin D Signaling in Cancer and Obesity

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 9, Iss. 3, 2009-09 ,pp. : 153-158

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Biomarkers, Molecular Imaging, and Novel Therapies of Cancer)

By  

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 331-332

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;2-AR-HIF-1&agr;: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis

By  

Current Molecular Medicine, Vol. 13, Iss. 6, 2013-01 ,pp. : 1023-1034

Bentham Science Publishers

Access to resources Recommend Favorite

Positive and negative signaling pathways

By Pratt J.C.   Sawasdikosol S.   van den Brink M.R.M.   Burakoff S.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 772-774

Elsevier

Access to resources Recommend Favorite